Neuropathic post-COVID pain symptomatology is not associated with serological biomarkers at hospital admission and hospitalization treatment in COVID-19 survivors

Neuropathic post-COVID pain symptomatology is not associated with serological biomarkers at hospital admission and hospitalization treatment in COVID-19 survivors

ObjectiveEvidence suggests that individuals who had survived to coronavirus disease, 2019 (COVID-19) could develop neuropathic post-COVID pain. This study investigated the association of serological biomarkers and treatments received during hospitalization with development of neuropathic-associated...

Full description

Bibliographic Details
Main Authors: César Fernández-de-las-Peñas, Carlos Guijarro, María Velasco-Arribas, Juan Torres-Macho, Ana Franco-Moreno, Andrea Truini, Oscar Pellicer-Valero, Lars Arendt-Nielsen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Medicine
Subjects:
COVID-19
neuropathic pain
post-COVID
biomarkers
hospitalization
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1301970/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1301970/full

Similar Items